Beauty Health (NASDAQ:SKIN) Upgraded to Strong-Buy at Zacks Research

Zacks Research upgraded shares of Beauty Health (NASDAQ:SKINFree Report) from a hold rating to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports.

SKIN has been the subject of several other research reports. Weiss Ratings raised shares of Beauty Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 8th. TD Cowen reduced their price objective on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. Roth Capital restated a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Finally, Canaccord Genuity Group lowered their target price on Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $2.02.

Read Our Latest Report on Beauty Health

Beauty Health Stock Performance

Shares of SKIN stock opened at $0.86 on Monday. The firm has a market capitalization of $111.84 million, a price-to-earnings ratio of -5.08 and a beta of 1.08. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. The business’s 50-day moving average price is $0.72 and its 200-day moving average price is $1.00. Beauty Health has a 12 month low of $0.55 and a 12 month high of $2.69.

Beauty Health (NASDAQ:SKINGet Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. The company had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%. Equities research analysts forecast that Beauty Health will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Beauty Health

A number of institutional investors have recently modified their holdings of SKIN. Diversified Trust Co bought a new position in Beauty Health during the first quarter worth $25,000. Public Employees Retirement System of Ohio bought a new stake in Beauty Health during the third quarter valued at $26,000. Atom Investors LP bought a new stake in Beauty Health during the fourth quarter valued at $29,000. CWM LLC grew its holdings in Beauty Health by 232.8% during the 4th quarter. CWM LLC now owns 22,018 shares of the company’s stock worth $31,000 after acquiring an additional 15,402 shares during the period. Finally, Franklin Resources Inc. acquired a new stake in Beauty Health during the 3rd quarter worth about $31,000. 93.26% of the stock is owned by institutional investors.

About Beauty Health

(Get Free Report)

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

Featured Stories

Analyst Recommendations for Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.